Source: International Congress 2019 – Treatments, adherence and psychosocial aspects of cystic fibrosis
Disease area: Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Keßler (Muenster, Germany), A. Dübbers (Muenster, Germany), J. Große-Onnebrink (Muenster, Germany), H. Omran (Muenster, Germany). Pregnancy in two patients with cystic fibrosis treated with lumacaftor/ivacaftor. 4517

Member's Comments

No comment yet.

Related content which might interest you: Outcomes of cystic fibrosis patients after spontaneous pneumothorax Source: Eur Respir J 2007; 30: Suppl. 51, 387s Year: 2007 Pulmonary hypertension in cystic fibrosis patients Source: Annual Congress 2008 - Cystic fibrosis: new mechanisms, monitoring and treatment tools Year: 2008 Pneumothorax in paediatric cystic fibrosis patients Source: Eur Respir J 2005; 26: Suppl. 49, 620s Year: 2005 Massive hemoptysis in cystic fibrosis adult patients Source: Annual Congress 2008 - Cystic fibrosis: factors affecting lung health Year: 2008 Does this patient have cystic fibrosis?  Source: International Congress 2017 – GR6 Paediatric Ground Round: an interactive session Year: 2017 Efficacy of alendronate/colecalciferol/calcium in adults with cystic fibrosis Source: Annual Congress 2010 - Cystic fibrosis: lung disease and much more Year: 2010 Comorbidities in cystic fibrosis Source: International Congress 2015 – Comorbidities in COPD and other chronic lung diseases Year: 2015 Characteristics of cystic fibrosis patients diagnosed after false negative cystic fibrosis newborn screening results Source: International Congress 2019 – Treatments, adherence and psychosocial aspects of cystic fibrosis Year: 2019 Compliance with treatment in UK children with cystic fibrosis Source: Eur Respir J 2001; 18: Suppl. 33, 538s Year: 2001 Cystic fibrosis and pregnancy Source: International Congress 2019 – Russian speaking programme 2019: Part II Year: 2019 The treatment burden of cystic fibrosis: a day-to-day experience with treatment as someone with cystic fibrosis Source: Breathe, 17 (1) 210013; 10.1183/20734735.0013-2021 Year: 2021 Efficacy of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis and advanced lung disease Source: Eur Respir J, 57 (2) 2003079; 10.1183/13993003.03079-2020 Year: 2021 Difficulties in optimizing vitamin D levels in paediatric cystic fibrosis patients Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment Year: 2014 Ergospirometry in children with cystic fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 229s Year: 2003 Microcirculation alterations in adult patients with cystic fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 262s Year: 2006 The ageing cystic fibrosis patient Source: International Congress 2018 – PG18 Cystic fibrosis: management in adult patients Year: 2018 Retrospective cohort study of adult cystic fibrosis patients colonised with achromobacter Xylosoxidans Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults Year: 2013 How useful is the lung ultrasound in cystic fibrosis? Source: International Congress 2016 – Cystic fibrosis: various aspects Year: 2016 Biomarkers of early relapse of pulmonary exacerbation in cystic fibrosis adult patients Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults Year: 2013